Chemistry of antineoplastic agents
Minerva Medica 62(28): 1492
1971
ISSN/ISBN: 0026-4806 PMID: 5567645 Document Number: 42365
Document emailed within 1 workday
Related Documents
Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
Wada, T.; Matsui, H. 2013: Research development of novel antineoplastic agents Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Berti, T. 1970: Specific histotropism of antineoplastic agents La Clinica Terapeutica 55(4): 293-303
Dybkaer, R. 1979: International Union of Pure and Applied Chemistry and International Federation of Clinical Chemistry. IUPAC Section on Clinical Chemistry Commission on Quantities and Units in Clinical Chemistry and IFCC Committee on Standards Expert Panel on Quantities and Units approved recommendation (1978). List of quantities in clinical chemistry Journal of Clinical Chemistry and Clinical Biochemistry 17(12): 822-835
Schmoll, H.J.; Hiddemann, W.; Rustum, Y.; Köhne-Wömpner, C.H. 1992: The emerging role for biomodulation of antineoplastic agents Seminars in Oncology 19(2 Suppl 3: 1-3
Orfi, L.; Wáczek, F.; Szabó, M.; Kövesdi, I.; Mészáros, G.; Idei, M.; Horváth, A.; Hollósy, F.; Mák, M.; Szegedi, Z.; Szende, B.; Kéri, G.; Noszál, B. 1999: Preparation and characterization of potential antineoplastic agents Acta Pharmaceutica Hungarica 69(3): 115-122
Takeuchi, A. 1980: Bronchial artery infusion of antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 38(7): 2683-2690
Babaian, I.S.; Khudaverdian, N.V.; Karapetian, L.G.; Kazarian, R.S.; Sogomonian, L.R. 1997: Comparative study of three antineoplastic alkylating agents on DNA Biofizika 42(2): 542-543
Kato, T.; Nemoto, R. 1982: Clinical application of microencapsulated antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 40(2): 478-488
Sakurai, Y. 1975: Deveolpment of new antineoplastic agents and their clinical characteristics Nihon Rinsho. Japanese Journal of Clinical Medicine 33(5): 1892-1896
Le Guern, M. 1987: DNA-topoisomerase II: Cellular targets of antineoplastic agents Pathologie-Biologie 35(4): 343-345
Matsumura, Y. 1982: Intravesical instillation of adriamycin and other antineoplastic agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 372-376
Presnova, Z.F.; Chernov, V.A. 1971: Effect of adrenomimetic agents on the antineoplastic activity of thiophosphamide Farmakologiia i Toksikologiia 34(4): 456-460
Cohen, S.C.; Gabelnick, H.L.; Johnson, R.K.; Goldin, A. 1975: Effects of antineoplastic agents on wound healing in mice Surgery 78(2): 238-244
Pashinskiĭ, V.G. 1972: The possibility of increasing the activity of antineoplastic agents by using diuretics Biulleten' Eksperimental'noi Biologii i Meditsiny 73(11): 82-84
Ashwin, J. 1983: Agencies cooperate in ensuring safe use of antineoplastic agents Canadian Medical Association Journal 128(8): 907-908